INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 79 filers reported holding INSTIL BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $11,585,000 | -3.3% | 2,393,683 | -7.7% | 0.14% | +3.6% |
| Q2 2022 | $11,983,000 | -16.4% | 2,593,781 | +94.5% | 0.14% | +9.6% |
| Q1 2022 | $14,332,000 | -35.1% | 1,333,227 | +3.4% | 0.12% | -29.4% |
| Q4 2021 | $22,070,000 | -2.5% | 1,289,899 | +1.9% | 0.18% | 0.0% |
| Q3 2021 | $22,640,000 | +77.1% | 1,266,271 | +11.2% | 0.18% | +84.4% |
| Q2 2021 | $12,782,000 | -52.6% | 1,138,705 | +6.0% | 0.10% | -52.5% |
| Q1 2021 | $26,953,000 | – | 1,074,700 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $16,255,471 | 100.00% |
| CPMG Inc | 8,218,467 | $3,517,504 | 1.92% |
| Western Standard LLC | 1,796,987 | $769,110 | 0.70% |
| Vivo Capital, LLC | 12,486,787 | $5,344,345 | 0.59% |
| Nantahala Capital Management | 1,000,000 | $428,000 | 0.04% |
| Baker Brothers Advisors | 4,704,395 | $2,013,481 | 0.01% |
| HCR Wealth Advisors | 40,000 | $17,120 | 0.00% |
| Hennion & Walsh Asset Management, Inc. | 98,080 | $41,978 | 0.00% |
| Long Focus Capital Management, LLC | 100,000 | $42,800 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 867,279 | $371,195 | 0.00% |